Antisoma says lung cancer drug data promising (Reuters)
Reuters - British cancer specialist Antisoma Plc
said on Monday it had received promising preliminary results
from an intermediate Phase II clinical trial of its AS1404
medicine as a treatment for lung cancer.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace